Apis Capital Advisors, LLC Sarepta Therapeutics, Inc. Transaction History

Apis Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $618,885 - $1.33 Million	-8,500 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$112.21 - $151.95 $168,315 - $227,924	-1,500 Reduced 15.0%	8,500 $1.29 Million
Q1 2019 May 07, 2019	SELL	$106.67 - $151.68 $213,340 - $303,360	-2,000 Reduced 16.67%	10,000 $1.19 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $1.17 Million - $1.79 Million	12,000 New	12,000 $1.31 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Apis Capital Advisors, LLC with notifications on news.